Messino Cancer Centers
Asheville, North Carolina, United States
Medical clinic in Asheville, North Carolina
551 Brevard Rd, Asheville, NC 28806
About Messino Cancer Centers
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
22
Alliance for Clinical Trials in Oncology
2
Hoffmann-La Roche
2
Daiichi Sankyo, Inc.
1
Denovo Biopharma LLC
1
ECOG-ACRIN Cancer Research Group
1
Effector Therapeutics
1
Eli Lilly and Company
1
Epizyme, Inc.
1
Genentech, Inc.
1
Hutchison Medipharma Limited
1
Clinical Trials at Messino Cancer Centers
During the past decade, Messino Cancer Centers conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 8 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 5 clinical trials were completed. i.e. 27.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
2008-08-01
2011-05-01
Completed
109
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
2010-02-15
2018-08-15
Completed
356
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
2011-05-25
Active, not recruiting
1,673
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
2011-01-06
Active, not recruiting
3,270
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
2012-06-04
2022-05-20
Completed
137
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2013-12-09
2024-01-19
Active, not recruiting
547
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Messino Cancer Centers" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Denovo Biopharma LLC"
with 1 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Messino Cancer Centers"
#1 collaborator was "NRG Oncology" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BeiGene" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Messino Cancer Centers
According to Clinical.Site data, the most researched conditions in "Messino Cancer Centers" are
"Chronic Lymphocytic Leukemia" (3 trials), "Recurrent Breast Carcinoma" (3 trials), "Small Lymphocytic Lymphoma" (3 trials), "Stage III Breast Cancer AJCC v7" (3 trials) and "Breast Ductal Carcinoma In Situ" (2 trials). Many other conditions were trialed in "Messino Cancer Centers" in a lesser frequency.
Clinical Trials Intervention Types at Messino Cancer Centers
Most popular intervention types in "Messino Cancer Centers" are "Drug" (34 trials), "Other" (24 trials), "Biological" (16 trials), "Procedure" (13 trials) and "Radiation" (7 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (13 trials), "Laboratory Biomarker Analysis" (11 trials), "Biospecimen Collection" (7 trials), "Computed Tomography" (7 trials) and "Placebo Administration" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Messino Cancer Centers
The vast majority of trials in "Messino Cancer Centers" are
37 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Messino Cancer Centers
Currently, there are NaN active trials in "Messino Cancer Centers".
undefined are not yet recruiting,
19 are recruiting,
19 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Messino Cancer Centers,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Messino Cancer Centers, 2 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 29 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".